Georg Hochleitner

Managing Director
Quick facts
18 years of experience in working for private equity funds
Specializes in commercial and operational due diligence, 100-day planning and performance improvement
Contact info
Download PDF  |  V-Card
Call
+49 151 171 463 61
Connect on
Georg Hochleitner is a Managing Director with Alvarez & Marsal’s Private Equity Performance Improvement practice in Munich. He brings 18 years of experience in working for private equity funds. His primary areas of concentration are commercial and operational due diligence, 100-day planning and performance improvement. Mr. Hochleitner has worked with clients in a range of industries including healthcare, pharmaceuticals, med-tech, business services, logistics, consumer goods, manufacturing and packaging.

Prior to joining A&M, Mr. Hochleitner spent three and a half years as a Partner with goetzpartners Management Consultants in Munich. During this period, he led close to 100 commercial and operational due diligence projects for both private equity and corporate clients. The target companies included, amongst many others, a leading international digital market place, one of the world’s largest manufacturers of hearing aids, a manufacturer of self-adhesive labels and flexible packaging material, a producer of complex rehab wheelchairs and a manufacturer of food processing equipment. Mr. Hochleitner was responsible for creating the PE practice and under his leadership, was quickly established as a highly regarded market leader in Germany.

Previously, Mr. Hochleitner was a Vice President at Rothgordt & Cie, an independent consulting firm offering strategy and transaction advice, as well as value enhancement programs to achieve sustainable value creation results for medium-to-large sized family-owned enterprises, divisions of multinational groups, leading private equity funds and family offices. Before Rothgordt & Cie, Mr. Hochleitner was a consultant and case team leader at Bain & Company.

Mr. Hochleitner earned a degree in business informatics from the University of Vienna, Austria, and a master’s degree in health policy and management from Harvard University. An Austrian national, he is fluent in German and English.